Brian Franz Appointed Chief Technology, Data & Analytics Officer of The Estée Lauder Companies
The Estée Lauder Companies Inc. (NYSE: EL) today announced the appointment of Brian Franz as Chief Technology, Data & Analytics Officer, effective April 21, 2025. Mr. Franz will report to President and Chief Executive Officer Stéphane de La Faverie and will join the company’s Executive Team.
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20250422797613/en/
Brian Franz Appointed Chief Technology, Data & Analytics Officer of The Estée Lauder Companies
“As we drive our bold Beauty Reimagined vision, Brian’s deep expertise and fresh perspectives will be pivotal in executing the biggest technology and operational transformation in our company’s history,” said Mr. de La Faverie. “Brian’s experience in modernizing infrastructure, building resilient and sustainable platforms, and advancing AI-driven capabilities will be critical as we accelerate our evolution into a more agile and consumer-focused organization. Brian’s strategic leadership, combined with his passion for innovation and talent development, makes him the ideal leader to shape the future of Technology, Data and Analytics at The Estée Lauder Companies.”
As the company’s first-ever combined Chief Data Technology, Data & Analytics Officer, Mr. Franz will be responsible for leading the strategic transformation of The Estée Lauder Companies’ global data and technology capabilities. Mr. Franz will drive the next era of technology innovation, empowering brands, commercial teams, and functions with scalable, secure, and advanced platforms that enhance business agility and deliver high-touch, personalized consumer experiences.
Mr. Franz will lead the company’s global Information Technology (IT) organization, guiding efforts to scale systems while ensuring they are agile enough to meet the changing needs of the business. Beyond IT, he will also oversee the Digital Technology & Experience and Enterprise Data teams, where they will focus on platform integration, delivering more seamless and personalized digital experiences for our consumers, and harnessing data as a strategic asset to drive faster, smarter decisions across the enterprise. As he leads this new chapter for The Estée Lauder Companies’ technology teams, Brian will leverage capabilities from key external technology partners to support additional modernization and innovation for the company.
Mr. de La Faverie added: “By bringing these critical areas together under one leader, we are simplifying our structure, removing operational silos, and creating stronger alignment across our data and technology strategies—key enablers of our Beauty Reimagined transformation.”
Mr. Franz joins The Estée Lauder Companies from State Street, where he most recently served as Executive Vice President, Global Chief Information Officer and Head of Enterprise Resiliency. In this role, he led global technology, enterprise resiliency and data for the organization. A seasoned executive with deep experience in technology, operations, and business transformation, Mr. Franz brings a technology-forward mindset and a history of scaling innovation in global enterprises—while keeping user experience and operational excellence at the center.
Prior to State Street, he held senior leadership roles at Diageo PLC, including Chief Productivity Officer and CIO, and served as CIO at PepsiCo International. Earlier in his career, he held leadership roles at GE, including GE Capital and AT&T. Mr. Franz holds a master’s degree from New York University and a bachelor’s degree from Iona College.
Cautionary Note Regarding Forward-Looking Statements
Statements in this press release may constitute forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. Such statements include those in the various quotations. Although the Company believes that its expectations are based on reasonable assumptions within the bounds of its knowledge of its business and operations, actual results may differ materially from the Company’s expectations. Factors that could cause actual results to differ from expectations include the ability to successfully implement the Company’s strategy, including Beauty Reimagined and the profit recovery and growth plan; successfully transition its leadership; and those other factors described in the Company’s filings with the Securities and Exchange Commission, including its most recent filings with the Securities and Exchange Commission. The Company assumes no responsibility to update forward-looking statements made herein or otherwise.
About The Estée Lauder Companies
The Estée Lauder Companies Inc. is one of the world’s leading manufacturers, marketers, and sellers of quality skin care, makeup, fragrance, and hair care products, and is a steward of luxury and prestige brands globally. The Company’s products are sold in approximately 150 countries and territories under brand names including: Estée Lauder, Aramis, Clinique, Lab Series, Origins, M·A·C, La Mer, Bobbi Brown Cosmetics, Aveda, Jo Malone London, Bumble and bumble, Darphin Paris, TOM FORD, Smashbox, AERIN Beauty, Le Labo, Editions de Parfums Frédéric Malle, GLAMGLOW, KILIAN PARIS, Too Faced, Dr.Jart+, the DECIEM family of brands, including The Ordinary and NIOD, and BALMAIN Beauty.
ELC-C
ELC-L
View source version on businesswire.com: https://www.businesswire.com/news/home/20250422797613/en/
Contacts
Media Relations:
Jill Marvin
jimarvin@estee.com
Investor Relations:
Rainey Mancini
rmancini@estee.com
(c) 2024 Business Wire, Inc., All rights reserved.
Business Wire, a Berkshire Hathaway company, is the global leader in multiplatform press release distribution.
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
Forrester Announces The EMEA Recipients Of Its 2025 Customer-Obsessed Enterprise Award21.5.2025 11:00:00 CEST | Press Release
Forrester (Nasdaq: FORR) today announced that Brenntag and e& are the winners of its 2025 Customer-Obsessed Enterprise Award for Europe, Middle East, and Africa (EMEA). The award recognises organisations that place their customers at the centre of their leadership, strategy, and operations to drive business outcomes, including building sustainable growth, customer loyalty, and employee engagement. Both recipients will be celebrated at CX Summit EMEA, a leading event for CX, B2C marketing, and digital leaders to learn best practices and receive actionable advice, being held in London and digitally from 2–4 June 2025. This year’s recognition highlights two firms: one leading the charge on customer obsession in the B2B sector and the other in B2C. Brenntag, a global leader in chemicals and ingredients distribution, has been selected for embedding customer obsession into its B2B operations spanning 72 countries. The firm earned the award for operationalising customer obsession through key
Legora Attracts $80 Million Series B Funding as Top Global Law Firms and Legal Teams Rush to Adopt Its Collaborative AI21.5.2025 10:00:00 CEST | Press Release
Today, Legora announces an $80 million funding round led by ICONIQ and General Catalyst, with continued support from existing investors Redpoint Ventures, Benchmark, and Y Combinator. This latest round is a strong endorsement of Legora’s product quality, velocity and the remarkable traction it has achieved globally—underscored by its rapid progression from inception to Series B in under two years. The deal comes as adoption of legal AI surges across the world. Legora is at the forefront of this shift - with lawyers across 250 firms and legal teams in 20 markets globally making daily use of its platform to review and research with precision, draft smarter, and collaborate seamlessly. Legora operates out of New York, London, and Stockholm, with 100 employees drawn from some of the world’s leading global law firms and tech companies. Max Junestrand, CEO and founder of Legora said: “The investment is a clear validation of the value our product is delivering to lawyers around the world. Whi
SEKISUI CHEMICAL: Victory in German Patent Infringement Lawsuit Concerning PVB Interlayer Films21.5.2025 10:00:00 CEST | Press Release
The High Performance Plastics Company (President : Akira Asano) of SEKISUI CHEMICAL CO., LTD. (President and Representative Director: Keita Kato; hereinafter “SEKISUI CHEMICAL”) hereby notifies that it has obtained judgments in its favor (hereinafter referred to as “the Judgments”) from the District Court Munich I on April 17, 2025, in the patent infringement litigation (docket No. 7 O 12401/24 and 7 O 12476/24) against Kuraray Europe GmbH (hereinafter referred to as “Kuraray Europe”), a subsidiary of Kuraray Co., Ltd which we previously announced in the press release dated October 16, 2024, titled “Filing of Lawsuit Seeking Injunction and Damages for Patent Infringement in Relation to PVB Interlayer in Germany.” This judgments found that the sound-insulating wedge products manufactured and sold by Kuraray Europe, namely “‘Trosifol’ The Wedge Acoustic” and “‘Trosifol’ The Wedge Acoustic Shadeband” (hereinafter collectively referred to as “Kuraray Products”) infringe European Patent No.
CCM Biosciences Announces Presentation of Data on its First-In-Class AML Drug Program at ASCO 202520.5.2025 22:30:00 CEST | Press Release
CCM Biosciences, a diversified pharmaceutical discovery and development company, today announced the upcoming presentation of its next-generation FLT3 inhibitor drug program for acute myeloid leukemia (AML) at the 2025 Annual Conference of the American Society of Clinical Oncology (ASCO), taking place May 30 to June 3 in Chicago. Acute Myeloid Leukemia (AML) is the most severe form of leukemia with few treatment options, and a malignancy frequently driven by mutations in the FMS-like tyrosine kinase 3 (FLT3) gene. The FLT3 internal tandem duplication (ITD) and tyrosine kinase domain (TKD) mutations, particularly D835 and F691, appear in approximately 30% of AML patients, often leading to poor prognosis and resistance to existing therapies. Gilteritinib (Xospata®; Astellas Pharma, peak annual sales projection: $1.5 billion) and Quizartinib (Vanflyta®; Daiichi Sankyo) are two FDA-approved FLT3 inhibitors, with the former approved only for relapsed/refractory AML and the latter approved o
IonQ Partners with Sweden’s Einride to Develop Quantum Supply Chain and Quantum-Enhanced Logistics for Autonomous Driving Solutions20.5.2025 22:05:00 CEST | Press Release
IonQ (NYSE: IONQ), a leading commercial quantum computing and networking company, today announced an investment partnership with Einride, a leading global freight mobility company that provides digital, electric, and autonomous technology to explore how quantum computing can drive the next generation of fleet optimization and logistics. Together, IonQ and Einride will develop quantum applications that address large-scale routing and scheduling problems that have traditionally challenged classical computing. By combining IonQ’s advanced quantum systems with Einride’s expertise in autonomous fleet logistics, the two companies will work to unlock new levels of efficiency, reliability, and sustainability for the global freight industry. “Einride shares our belief that quantum computing will fundamentally reshape and improve how large industries such as transportation and logistics operate,” said Niccolo de Masi, CEO of IonQ. “This partnership is aimed at creating a powerful platform with u
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom